Tower Research Capital (TRC)’s Annovis Bio ANVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,784
| Closed | -$2.68K | – | 5245 |
|
|
2025
Q1 | $2.68K | Buy |
1,784
+16
| +0.9% | +$24 | ﹤0.01% | 4517 |
|
|
2024
Q4 | $8.89K | Sell |
1,768
-1,319
| -43% | -$6.64K | ﹤0.01% | 3958 |
|
|
2024
Q3 | $24.9K | Sell |
3,087
-3,771
| -55% | -$30.4K | ﹤0.01% | 3110 |
|
|
2024
Q2 | $39.5K | Buy |
6,858
+2,060
| +43% | +$11.9K | ﹤0.01% | 3276 |
|
|
2024
Q1 | $57.1K | Buy |
4,798
+4,376
| +1,037% | +$52.1K | ﹤0.01% | 2182 |
|
|
2023
Q4 | $7.89K | Sell |
422
-220
| -34% | -$4.11K | ﹤0.01% | 4566 |
|
|
2023
Q3 | $6.09K | Buy |
642
+123
| +24% | +$1.17K | ﹤0.01% | 4645 |
|
|
2023
Q2 | $7.42K | Sell |
519
-2,042
| -80% | -$29.2K | ﹤0.01% | 4552 |
|
|
2023
Q1 | $39K | Buy |
2,561
+1,036
| +68% | +$15.8K | ﹤0.01% | 2722 |
|
|
2022
Q4 | $21K | Sell |
1,525
-165
| -10% | -$2.27K | ﹤0.01% | 3074 |
|
|
2022
Q3 | $23K | Buy |
+1,690
| New | +$23K | ﹤0.01% | 3803 |
|
|
2022
Q1 | – | Sell |
-669
| Closed | -$12K | – | 6062 |
|
|
2021
Q4 | $12K | Buy |
669
+442
| +195% | +$7.93K | ﹤0.01% | 4254 |
|
|
2021
Q3 | $7K | Buy |
+227
| New | +$7K | ﹤0.01% | 4621 |
|
|
2021
Q2 | – | Sell |
-2,259
| Closed | -$63K | – | 5440 |
|
|
2021
Q1 | $63K | Buy |
2,259
+1,481
| +190% | +$41.3K | ﹤0.01% | 2924 |
|
|
2020
Q4 | $6K | Sell |
778
-458
| -37% | -$3.53K | ﹤0.01% | 4528 |
|
|
2020
Q3 | $6K | Buy |
1,236
+208
| +20% | +$1.01K | ﹤0.01% | 4276 |
|
|
2020
Q2 | $4K | Buy |
+1,028
| New | +$4K | ﹤0.01% | 4327 |
|